Scan to downloadOtsuka Holdings Co., Ltd. (4578) Earnings Releases & Disclosures
| Date | Type | Title | Files |
|---|---|---|---|
| 2026-10-30 | Earnings Release | Consolidated Financial Results for the Nine-Month Period Ended September 30, 2026 [IFRS] | |
| 2026-10-30 | Treasury Shares | Notification of Completion of Share Repurchase and Number of Treasury Stock to be Cancelled | |
| 2026-10-30 | — | Notice Regarding Transition to a Company with an Audit and Supervisory Committee | |
| 2026-10-23 | — | Otsuka Presents Final Phase 3 VISIONARY Results for VOYXACT at ASN | |
| 2026-10-07 | — | Otsuka Completes Rolling Submission of Supplemental Biologics License Application (sBLA) for Traditional Approval of VOYXACT in U.S. | |
| 2026-10-02 | — | NDA Submission Initiated for Zipalertinib Plus Chemotherapy in First-Line EGFR Exon 20 Insertion Mutation NSCLC for Review Under FDA RTOR Program | |
| 2026-10-01 | Treasury Shares | Notice regarding the status of share repurchases | |
| 2026-09-14 | — | Zipalertinib Plus Chemotherapy Demonstrates 6-Month Median PFS Benefit in Phase 3 Trial in First-Line EGFR Exon 20 Insertion Mutation NSCLC | |
| 2026-09-01 | Treasury Shares | Notice regarding the status of share repurchases | |
| 2026-08-13 | — | Zipalertinib Plus Chemotherapy Meets Primary PFS Endpoint in Planned Interim Analysis of Phase 3 REZILIENT3 Trial | |
| 2026-08-04 | — | Otsuka Unveils Phase3 VISIONARY Two-Year eGFR Results Demonstrating VOYXACT(sibeprenlimab-szsi) Stabilizes Kidney Function Decline in IgAN | |
| 2026-08-03 | Treasury Shares | Notice regarding the status of share repurchases | |
| 2026-07-31 | Earnings Release | Consolidated Financial Results for the Six-Month Period Ended June 30, 2026 [IFRS] | |
| 2026-07-31 | Forecast Revision | Notice Regarding Revision of Full-Year Consolidated Financial Forecast and Payment of Interim Dividend and Revision of Year-End Dividend Forecast (Inc | |
| 2026-07-28 | Forecast Revision | Notice Regarding Revisions of Consolidated Results Forecast for the first half of FY2026 |
TDnet keeps only 31 days; this site accumulates daily and cannot backfill earlier disclosures.